ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS
The proofs of necessity of active arterial hypertension (AH) treatment in elderly patients are given. Peculiarities of pathogenesis of AH in elderly patients, connected predominantly with loss of big arteries elasticity and reasoning widely spread of isolated systolic AH in these patients, are discu...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Kitap |
| Baskı/Yayın Bilgisi: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
| Konular: | |
| Online Erişim: | Connect to this object online. |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b078df2d83c84662bf596c9d67b45f8a | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Y. A. Karpov |e author |
| 700 | 1 | 0 | |a V. V. Buza |e author |
| 245 | 0 | 0 | |a ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS |
| 260 | |b Столичная издательская компания, |c 2016-01-01T00:00:00Z. | ||
| 500 | |a 1819-6446 | ||
| 500 | |a 2225-3653 | ||
| 500 | |a 10.20996/1819-6446-2006-2-1-59-63 | ||
| 520 | |a The proofs of necessity of active arterial hypertension (AH) treatment in elderly patients are given. Peculiarities of pathogenesis of AH in elderly patients, connected predominantly with loss of big arteries elasticity and reasoning widely spread of isolated systolic AH in these patients, are discussed. Advantages of dihydropyridine calcium antagonists (DPCA) for AH treatment in elderly patients are proved, safety of treatment with DPCA is discussed. Data of clinical studies is analyzed. Analysis of target levels of blood pressure for antihypertensive treatment in elderly hypertensive patients is made. As a conclusion DPCA are the medicines of choice for AH treatment in elderly patients. | ||
| 546 | |a EN | ||
| 546 | |a RU | ||
| 690 | |a dihydropyridine calcium antagonists | ||
| 690 | |a elderly patients | ||
| 690 | |a isolated systolic arterial hypertension | ||
| 690 | |a target levels of blood pressure | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Diseases of the circulatory (Cardiovascular) system | ||
| 690 | |a RC666-701 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 2, Iss 1, Pp 59-63 (2016) | |
| 787 | 0 | |n https://www.rpcardio.online/jour/article/view/1006 | |
| 787 | 0 | |n https://doaj.org/toc/1819-6446 | |
| 787 | 0 | |n https://doaj.org/toc/2225-3653 | |
| 856 | 4 | 1 | |u https://doaj.org/article/b078df2d83c84662bf596c9d67b45f8a |z Connect to this object online. |